SEASTAR MEDICAL HOLDING CORPORATION Financials SeaStar Medical Holding Corporation
Equities
ICU
US81256L1044
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.403 USD | -6.47% |
|
-10.16% | -8.97% |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 |
|---|---|---|---|
| Capitalization 1 | 52.07 | 19.7 | 30.39 |
| Enterprise Value (EV) 1 | 52.07 | 19.7 | 30.39 |
| P/E ratio | -1.46 x | - | -0.66 x |
| Yield | - | - | - |
| Capitalization / Revenue | - | - | 33.8 x |
| EV / Revenue | - | - | 33.8 x |
| EV / EBITDA | - | - | - |
| EV / FCF | - | - | - |
| FCF Yield | - | - | - |
| Price to Book | - | - | - |
| Nbr of stocks (in thousands) | 12,700 | 44,500 | 75,419 |
| Reference price 2 | 4.100 | 0.4427 | 0.4030 |
| Announcement Date | 23-03-30 | 24-04-16 | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net sales 1 | - | - | 0.9 |
| EBITDA | - | - | - |
| EBIT 1 | - | -14.21 | -24.78 |
| Operating Margin | - | - | -2,753.78% |
| Earnings before Tax (EBT) 1 | - | -26.23 | -25.68 |
| Net income 1 | -23.01 | -26.23 | -25.68 |
| Net margin | - | - | -2,853.33% |
| EPS 2 | -2.800 | - | -0.6100 |
| Free Cash Flow | - | - | - |
| FCF margin | - | - | - |
| FCF Conversion (EBITDA) | - | - | - |
| FCF Conversion (Net income) | - | - | - |
| Dividend per Share | - | - | - |
| Announcement Date | 23-03-30 | 24-04-16 | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | - | - | 0.1 | 0.3 | 0.5 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | -4.581 | -3.75 | -2.936 | -2.943 | -5.648 | -5.568 | -5.993 | -7.574 |
| Operating Margin | - | - | - | - | - | -5,568% | -1,997.67% | -1,514.8% |
| Earnings before Tax (EBT) 1 | -5.262 | -3.664 | -7.426 | -9.88 | -5.872 | -5.792 | -6.217 | -7.798 |
| Net income 1 | -5.262 | -3.669 | -7.426 | -9.875 | -5.872 | -5.792 | -6.217 | -7.798 |
| Net margin | - | - | - | - | - | -5,792% | -2,072.33% | -1,559.6% |
| EPS 2 | -0.4000 | -0.2500 | -0.3700 | - | -0.1500 | -0.1400 | -0.1400 | -0.1800 |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 23-05-15 | 23-08-14 | 23-11-14 | 24-04-16 | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Debt | - | - | - |
| Net Cash position | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - |
| Free Cash Flow | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - |
| Assets 1 | - | - | - |
| Book Value Per Share | - | - | - |
| Cash Flow per Share | - | - | - |
| Capex | - | - | - |
| Capex / Sales | - | - | - |
| Announcement Date | 23-03-30 | 24-04-16 | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.403
USD
Average target price
2
USD
Spread / Average Target
+396.28%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -8.97% | 30.39M | |
| +73.46% | 12.41B | |
| -15.61% | 8.23B | |
| +3.88% | 6.46B | |
| +14.69% | 5.5B | |
| -5.53% | 5.33B | |
| +42.58% | 5.1B | |
| -19.05% | 4.05B | |
| -32.61% | 2.54B | |
| +10.80% | 1.99B |
- Stock Market
- Equities
- ICU Stock
- Financials SeaStar Medical Holding Corporation